Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholder's Equity

v3.22.0.1
Consolidated Statements of Stockholder's Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance at beginning of period (in shares) at Dec. 31, 2018     69,551,000        
Balance at beginning of period at Dec. 31, 2018 $ 399,936 $ (268) $ 7 $ 493,287 $ 272 $ (93,630) $ (268)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued pursuant to equity awards, net (in shares)     2,132,000        
Common stock issued pursuant to equity awards, net 140     140      
Employee stock purchase plan (in shares)     248,000        
Employee stock purchase plan 4,109     4,109      
Stock-based compensation 32,060     32,060      
Net current period other comprehensive income (loss) (1,159)       (1,159)    
Net income (loss) (19,898)         (19,898)  
Balance at end of period (in shares) at Dec. 31, 2019     71,931,000        
Balance at end of period at Dec. 31, 2019 414,920   $ 7 529,596 (887) (113,796)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued pursuant to equity awards, net (in shares)     1,515,000        
Common stock issued pursuant to equity awards, net 3,997     3,997      
Common stock issued for merger, net (in shares)     804,000        
Common stock issued for merger, net 17,080     17,080      
Employee stock purchase plan (in shares)     286,000        
Employee stock purchase plan 3,794     3,794      
Stock-based compensation 47,597     47,597      
Net current period other comprehensive income (loss) 2,322       2,322    
Net income (loss) (98,593)         (98,593)  
Balance at end of period (in shares) at Dec. 31, 2020     74,536,000        
Balance at end of period at Dec. 31, 2020 $ 391,117   $ 7 602,064 1,435 (212,389)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Repurchase of common stock (in shares) (454,372)   (455,000)        
Repurchase of common stock $ (23,548)     (23,548)      
Common stock issued pursuant to equity awards, net (in shares)     2,501,000        
Common stock issued pursuant to equity awards, net 14,614   $ 1 14,613      
Employee stock purchase plan (in shares)     196,000        
Employee stock purchase plan 4,998     4,998      
Stock-based compensation 59,358     59,358      
Net current period other comprehensive income (loss) 690       690    
Net income (loss) 41,969         41,969  
Balance at end of period (in shares) at Dec. 31, 2021     76,778,000        
Balance at end of period at Dec. 31, 2021 $ 489,198   $ 8 $ 657,485 $ 2,125 $ (170,420)